Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2011-03-29
2011-03-29
Navarro, Mark (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S001410, C424S085200, C424S085400, C424S150100, C424S154100, C424S159100, C424S161100, C424S164100, C424S189100, C424S196110, C424S197110, C424S201100, C424S231100, C424S236100, C424S241100, C424S278100, C435S007240, C435S334000, C530S388230, C530S388400, C530S389600
Reexamination Certificate
active
07914791
ABSTRACT:
A method for stimulating the immune response to a vaccine applied to a mammalian subject includes the step of administering to the subject an effective amount of EtxB or a molecule having substantially equivalent activity, free from whole toxin and not linked to an antigen.
REFERENCES:
patent: 5182109 (1993-01-01), Tamura et al.
patent: 5241053 (1993-08-01), Fujisawa et al.
patent: 5681571 (1997-10-01), Holmgren et al.
patent: 6019973 (2000-02-01), Holmgren et al.
patent: 6103243 (2000-08-01), Russell-Jones et al.
patent: 6413523 (2002-07-01), Clements
patent: 2003261492 (2003-12-01), None
patent: 2003261492 (2006-09-01), None
patent: 2006249261 (2007-01-01), None
patent: 2331832 (1999-11-01), None
patent: 372928 (1989-06-01), None
patent: 0372928 (1990-06-01), None
patent: 919243 (1997-11-01), None
patent: 0 722 340 (1998-04-01), None
patent: 0 222 835 (2000-04-01), None
patent: 2 217 600 (1989-11-01), None
patent: 20002613 (2009-08-01), None
patent: WO 96/34893 (1996-11-01), None
patent: WO 97/02045 (1997-01-01), None
patent: WO 99/26654 (1999-06-01), None
patent: WO 99/36088 (1999-07-01), None
patent: 99/58145 (1999-11-01), None
patent: 99/58145 (2000-02-01), None
Marcello et al. (Proc. Natl. Acad. Sci. USA, vol. 91, pp. 8994-8998, Sep. 1994).
Hazama et al. 1993. Immunology. vol. 78(4): 643-649.
Cruse et al. 1995. Illustrated Dictionary of Immunology. CRC Press Inc. pp. 18-19, 33, 152 and 192.
Richards et al., (1997. Vaccine. vol. 15(10): 1065-1069).
Wu and Russel (1998), Vaccine. 16(2-3):286-92.
Norwegain Office Action, Application No. 2000 5599, Date: Jul. 2, 2009 (with English translation).
International Prelminary Examination Report, App. No. PCT/GB99/01461, Date: Jul. 10, 2000.
Examination Report, Application No. EP99922284.7, Date: Sep. 21, 2007.
Examination Report, Application No. EP99922284.7, Date: Aug. 31, 2004.
Examination Report, Application No. EP9992284.7, Date: Jul. 22, 2003.
Examination Report, Application No. AU2003261492, Date: Jun. 15, 2005.
Examination Report, Application No. AU39394/99, Date: Jul. 21, 2003.
Examination Report, Application No. AU39394/99, Date: Feb. 8, 2002.
Office Action, Application No. CA2331832, Date: Mar. 2, 2009.
Japanese Office Action, Application No. JP2000-547996, Mail Date: Jun. 4, 2009 (with English Translation).
Blanchard et al. (1998), Immunology, 94(1):22-27.
Matousek et al. (1996), Journal of Immunology, 156(11):4137-45.
Vadolas et al. (1995), Eur J Immunology, 25(4):969-75.
Hirst, T.R., et al., J. Applied Microbiology Symp. Supp. 84: 26S-34S (1998).
Nashar, T.O., et al., Immunology, 91: 572-578 (1997).
Nashar, T.O., et al., Med. Microbiol. Immunol. 187: 3-10 (1998).
Richards, C.M., et al., J. Infect. Dis. 177: 1451-1457 (1998).
Williams, N.A., et al., Immunology Today 20: 95-101 (1999).
Zhang, T., et al., Infect. & Immun. 63: 1349-1355 (1995).
Boirivant, M., et al., The Journal of Immunology, 2001, 166: 3522-3532.
Sobel, D.O., et al., Diabetes, 1998, 47: 186-191.
Tamura et al., “Escherichia coliheat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine”, Vaccine (1994), 12(12):1083-1089.
Bird Lucy Amber
Hirst Timothy Raymond
Morgan Andrew
Williams Neil Andrew
Wilson Andrew Douglas
Hines Ja'na
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Navarro Mark
Trident Pharmaceuticals, Inc.
LandOfFree
Vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2752103